These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21033017)

  • 1. The pharmacology of anaesthetics in the neonate.
    Anderson BJ; Allegaert K
    Best Pract Res Clin Anaesthesiol; 2010 Sep; 24(3):419-31. PubMed ID: 21033017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology in the very young: anaesthetic implications.
    Anderson BJ
    Eur J Anaesthesiol; 2012 Jun; 29(6):261-70. PubMed ID: 22543573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics in the elderly.
    Vuyk J
    Best Pract Res Clin Anaesthesiol; 2003 Jun; 17(2):207-18. PubMed ID: 12817915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do we really know the pharmacodynamics of anaesthetics used in newborns, infants and children? A review of the experimental and clinical data on neurodegeneration.
    Bartkowska-Śniatkowska A; Rosada-Kurasińska J; Zielińska M; Bienert A
    Anaesthesiol Intensive Ther; 2014; 46(2):101-8. PubMed ID: 24858970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics in newborns and infants].
    Röper A; Lauven PM
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Oct; 34(10):616-25. PubMed ID: 10548958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic population modelling in paediatric anaesthesia and its clinical translation.
    Morse JD; Hannam J; Anderson BJ
    Curr Opin Anaesthesiol; 2019 Jun; 32(3):353-362. PubMed ID: 31045640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic interactions in anaesthesia. A review of current knowledge and how it can be used to optimize anaesthetic drug administration.
    van den Berg JP; Vereecke HE; Proost JH; Eleveld DJ; Wietasch JK; Absalom AR; Struys MM
    Br J Anaesth; 2017 Jan; 118(1):44-57. PubMed ID: 28039241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).
    Besunder JB; Reed MD; Blumer JL
    Clin Pharmacokinet; 1988 Apr; 14(4):189-216. PubMed ID: 3292100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.
    De Paepe P; Belpaire FM; Buylaert WA
    Clin Pharmacokinet; 2002; 41(14):1135-51. PubMed ID: 12405864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic optimisation of general anaesthesia in pregnancy.
    Gin T
    Clin Pharmacokinet; 1993 Jul; 25(1):59-70. PubMed ID: 8354017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental pharmacology: neonates are not just small adults..
    Allegaert K; Verbesselt R; Naulaers G; van den Anker JN; Rayyan M; Debeer A; de Hoon J
    Acta Clin Belg; 2008; 63(1):16-24. PubMed ID: 18386761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
    Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
    Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic implications for the clinical use of propofol.
    Kanto J; Gepts E
    Clin Pharmacokinet; 1989 Nov; 17(5):308-26. PubMed ID: 2684471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs.
    Björkman S
    Br J Clin Pharmacol; 2005 Jun; 59(6):691-704. PubMed ID: 15948934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of drugs in neonates: pattern recognition beyond compound specific observations.
    Smits A; Kulo A; de Hoon JN; Allegaert K
    Curr Pharm Des; 2012; 18(21):3119-46. PubMed ID: 22564304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is indirect hyperbilirubinemia a useful biomarker of reduced propofol clearance in neonates?
    Smits A; De Cock RF; Cossey V; Knibbe CA; Allegaert K
    Biomark Med; 2012 Jun; 6(3):283-9. PubMed ID: 22731901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics.
    Donovan MD; Boylan GB; Murray DM; Cryan JF; Griffin BT
    Br J Clin Pharmacol; 2016 Jan; 81(1):62-77. PubMed ID: 26302437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic drug interactions in anaesthetic practice.
    Wood M
    Clin Pharmacokinet; 1991 Oct; 21(4):285-307. PubMed ID: 1760901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs.
    Mandema JW; Danhof M
    Clin Pharmacokinet; 1992 Sep; 23(3):191-215. PubMed ID: 1511536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.